SynthesisFrontiers in pharmacology2022

Efficacy and safety of baricitinib and tocilizumab in hospitalized patients with COVID-19: A comparison using systematic review and meta-analysis.

Jerin Jose Cherian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.